Patrycja Bielawiec

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol

E. Harasim-Symbor, A. Chabowski, Patrycja Bielawiec, 2020, Frontiers in Endocrinology.

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis

E. Harasim-Symbor, A. Chabowski, Karolina Konstantynowicz-Nowicka, 2023, Scientific Reports.

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity

E. Harasim-Symbor, A. Chabowski, Klaudia Sztolsztener, 2020, Biomolecules.

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity

E. Harasim-Symbor, A. Chabowski, Tomasz Charytoniuk, 2022, International journal of molecular sciences.

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity

E. Harasim-Symbor, A. Chabowski, Klaudia Sztolsztener, 2021, Nutrients.

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

E. Harasim-Symbor, A. Chabowski, Klaudia Sztolsztener, 2020, Biomolecules.

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes

B. Malinowska, I. Kasacka, E. Harasim-Symbor, 2020, Molecules.

High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD

I. Kasacka, E. Harasim-Symbor, A. Chabowski, 2019, International journal of molecular sciences.

Cannabigerol–A useful agent restoring the muscular phospholipids milieu in obese and insulin-resistant Wistar rats?

E. Harasim-Symbor, A. Chabowski, Klaudia Sztolsztener, 2024, Frontiers in molecular biosciences.